HexaPro(Vaxxas)

N/A

Report date: 2023/06/07 16:05:11

Base Information

Drug NameHexaPro(Vaxxas)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVaxxas
China Registration ClassN/A

Develop Information

Active CompaniesVaxxas
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A